Immunovia AB Statistics

Total Valuation

Immunovia AB has a market cap or net worth of GBP 5.85 million. The enterprise value is 1.96 million.

Market Cap	5.85M
Enterprise Value	1.96M

Important Dates

The next estimated earnings date is Tuesday, February 25, 2025.

Earnings Date	Feb 25, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+81.75%
Shares Change (QoQ)	+54.94%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	152.16M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	2.18
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-0.21
EV / Sales	42.14
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.36, with a Debt / Equity ratio of 0.04.

Current Ratio	2.36
Quick Ratio	2.36
Debt / Equity	0.04
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-8.29

Financial Efficiency

Return on equity (ROE) is -195.17% and return on invested capital (ROIC) is -81.03%.

Return on Equity (ROE)	-195.17%
Return on Assets (ROA)	-60.81%
Return on Capital (ROIC)	-81.03%
Revenue Per Employee	5,166
Profits Per Employee	-1.05M
Employee Count	11
Asset Turnover	0.01
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -74.78% in the last 52 weeks. The beta is 1.44, so Immunovia AB's price volatility has been higher than the market average.

Beta (5Y)	1.44
52-Week Price Change	-74.78%
50-Day Moving Average	1.44
200-Day Moving Average	17.69
Relative Strength Index (RSI)	26.18
Average Volume (20 Days)	32,930

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Immunovia AB had revenue of GBP 46,492 and -9.46 million in losses. Loss per share was -0.17.

Revenue	46,492
Gross Profit	46,492
Operating Income	-7.61M
Pretax Income	-9.46M
Net Income	-9.46M
EBITDA	-7.65M
EBIT	-7.61M
Loss Per Share	-0.17

Full Income Statement

Balance Sheet

The company has 3.99 million in cash and 110,050 in debt, giving a net cash position of 3.88 million.

Cash & Cash Equivalents	3.99M
Total Debt	110,050
Net Cash	3.88M
Net Cash Per Share	n/a
Equity (Book Value)	2.84M
Book Value Per Share	0.02
Working Capital	2.46M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-7.13M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	100.00%
Operating Margin	-16,370.82%
Pretax Margin	-20,352.92%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Immunovia AB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-81.75%
Shareholder Yield	-81.75%
Earnings Yield	-161.81%
FCF Yield	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Immunovia AB has an Altman Z-Score of -28.13. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-28.13
Piotroski F-Score	n/a